Management of Antithrombotic Therapy in Adults with Immune Thrombocytopenia (ITP): A Survey of ITP Specialists and General Hematologist-Oncologists

While patients with immune thrombocytopenia (ITP) and low platelet counts are at risk for bleeding, they are not protected against arterial and venous thrombotic events. Frequently, hematologists are asked to consult on a patient with ITP requiring an antiplatelet (AP) agent or anticoagulant (AC). N...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thromb Thrombolysis
Autores principales: Pishko, Allyson M., Misgav, Mudi, Cuker, Adam, Cines, Douglas B., George, James N., Vesely, Sara K., Terrell, Deirdra R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355248/
https://ncbi.nlm.nih.gov/pubmed/29582213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-018-1649-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares